nVerses Capital’s Colgate-Palmolive CL Stock Holding History

nVerses Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,251	Closed	-$448K	–	336
2026 Q1	$448K	Buy	+5,251	New	+$468K	0.41%	69

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

nVerses Capital's CL Position: Q2 2026 in Review

nVerses Capital sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 5,251 shares — an estimated $448K sold.

nVerses Capital first reported a position in CL in Q1 2026 and held it in 1 quarter. The position peaked at $448K in Q1 2026. 1,744 funds tracked by Wall St. Rank hold CL as of Q2 2026.

nVerses Capital reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 5,251 Colgate-Palmolive shares in Q2 2026, an estimated $448K.
nVerses Capital first reported a position in Colgate-Palmolive in Q1 2026 and held it in 1 quarter.
nVerses Capital's Colgate-Palmolive position peaked at $448K in Q1 2026.
1,744 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.